• 1
    Beauchamp TL, Childress JF. Principles of biomedical ethics, 5th edition. New York: Oxford University Press, 2001.
  • 2
    Cheng JD, Hitt J, Koczwara B, et al. Impact of quality of life on patient expectations regarding Phase I clinical trials. J Clin Oncol. 2000; 18: 421428.
  • 3
    Siminoff LA, Fetting JH, Abeloff MD. Doctor-patient communication about breast cancer adjuvant therapy. J Clin Oncol. 1989; 7: 11921200.
  • 4
    Lee SJ, Fairclough D, Antin JH, Weeks JC. Discrepancies between patient and physician estimates for the success of stem cell transplantation. JAMA. 2001; 285: 10341038.
  • 5
    Daugherty CK. Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective. J Clin Oncol. 1999; 17: 16011617.
  • 6
    Meropol NJ., Schulman KA, Weinfurt K, et al. Discordant perceptions of patients and their physicians regarding Phase I trials [abstract]. Proc Am Soc Clin Oncol. 2002; 21: 245a.
  • 7
    Daugherty C, Ratain MJ, Grochowski E, et al. Perceptions of cancer patients and their physicians involved in Phase I trials. J Clin Oncol. 1995; 13: 10621072.
  • 8
    Kahneman D, Tversky A. Variants of uncertainty. Cognition. 1982; 11: 143157.
  • 9
    Hacking I. The emergence of probability: a philosophical study of early ideas about probability, induction, and statistical inference. New York: Cambridge University Press, 1975.
  • 10
    Hacking I. An introduction to probability and inductive logic. Cambridge: Cambridge University Press, 2001.
  • 11
    Degner LF, Kristjanson LJ, Bowman D, et al. Information needs and decisional preferences in women with breast cancer. JAMA. 1997; 277: 14851492.
  • 12
    The EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990; 16: 199208.
  • 13
    Ganz PA, Lee JJ, Siau J. Quality of life assessment: an independent prognostic variable for survival in lung cancer. Cancer. 1991; 67: 31313135.
  • 14
    Gaskin DJ, Kong J, Meropol NJ, Yabroff KR, Weaver C, Schulman KA. Treatment choices by seriously ill patients: the Health Stock Risk Adjustment model. Med Decis Making. 1998; 18: 8494.
  • 15
    O'Connor AM. Validation of a decisional conflict scale. Med Decis Making. 1995; 15: 2530.
  • 16
    Stiggelbout AM, Kiebert GM, Kievit J, Leer JW, Stoter G, de Haes JC. Utility assessment in cancer patients: adjustment of time tradeoff scores for the utility of life years and comparison with standard gamble scores. Med Decis Making. 1994; 14: 8290.
  • 17
    Verhoef LC, de Haan AF, van Daal WA. Risk attitude in gambles with years of life: empirical support for prospect theory. Med Decis Making. 1994; 14: 194200.
  • 18
    Von Neuman J, Morgenstern O. Theory of games and economic behavior, 2nd edition. Princeton: Princeton University Press, 1947.
  • 19
    Ware J Jr., Kosinski M, Keller SD. SF-12: how to score the SF-12 Physical and Mental Health Summary Scales. Boston: The Health Institute, New England Medical Center, 1995.
  • 20
    Ware J Jr., Kosinski M, Keller SD. A 12-item short- form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34: 220233.
  • 21
    Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey: manual and interpretation guide. Boston: The Health Institute, New England Medical Center, 1993.
  • 22
    Grossman M. On the concept of health capital and the demand for health. J Pol Econ. 1972; 80: 168199.
  • 23
    Schafer JL. Analysis of incomplete multivariate data. Boca Raton: Chapman & Hall/CRC, 1997.
  • 24
    Savitz DA, Olshan AF. Multiple comparisons and related issues in the interpretation of epidemiologic data. Am J Epidemiol. 1995; 142: 904908.
  • 25
    Ghiselli EE, Campbell JP, Zedeck S. Measurement theory for the behavioral sciences. San Francisco: WH Freeman and Company, 1981.